Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Autor: Gately L; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. lucy.gately@mh.org.au.; Department of Medical Oncology, Alfred Health, Prahran, VIC, Australia. lucy.gately@mh.org.au., Mesía C; Medical Oncology Service, Institut Català d'Oncologia, Hospitalet de Llobregat, Spain., Sepúlveda JM; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain., Del Barco S; Medical Oncology Service, Institut Català d'Oncologia Girona, Girona, Spain., Pineda E; Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain., Gironés R; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain., Fuster J; Medical Oncology Service, Hospital Son Espases, Palma De Mallorca, Spain., Dumas M; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Gill S; Department of Medical Oncology, Alfred Health, Prahran, VIC, Australia., Navarro LM; Medical Oncology Service, Hospital de Salamanca, Salamanca, Spain., Herrero A; Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain., Dowling A; Department of Medical Oncology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia., de Las Peñas R; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain., Vaz MA; Medical Oncology Service, Hospital Ramón y Cajal, Madrid, Spain., Alonso M; Medical Oncology Service, Hospital Virgen del Rocio, Sevilla, Spain., Lwin Z; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Herston, QLD, Australia., Harrup R; Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia., Peralta S; Medical Oncology Service, Hospital Sant Joan de Reus, Reus, Spain., Long A; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia., Perez-Segura P; Medical Oncology Service, Hospital Clinico San Carlos, Madrid, Spain., Ahern E; Department of Medical Oncology, Monash Health, Bentleigh, VIC, Australia., Garate CO; Medical Oncology Service, Hospital Universitario Fundación Alcorocón, Alcorcón, Spain., Wong M; Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia., Campbell R; Department of Medical Oncology, Bendigo Health, Bendigo, VIC, Australia., Cuff K; Department of Medical Oncology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Jennens R; Department of Medical Oncology, Epworth Health, Insert City, VIC, Australia., Gallego O; Medical Oncology Service, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Underhill C; Department of Medical Oncology, Border Medical Oncology Research Unit, East Albury, NSW, Australia.; University of New South Wales Rural Medical School, Albury Campus, Albury, NSW, Australia., Martinez-Garcia M; Medical Oncology Service, Hospital del Mar, Barcelona, Spain., Covela M; Medical Oncology Service, Hospital Lucus Augusti, Lugo, Spain., Cooper A; Department of Medical Oncology, Liverpool Hospital, Liverpool, NSW, Australia., Brown S; Department of Medical Oncology, Ballarat Health Services, Ballarat, VIC, Australia., Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Torres J; Department of Medical Oncology, Goulburn Valley Health, Melbourne, VIC, Australia., Collins IM; Department of Medical Oncology, South West Regional Cancer Centre, Warrnambool, VIC, Australia., Gibbs P; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Balana C; Medical Oncology Service, Institut Català d'Oncologia Girona, Badalona, Spain.; Applied Research Group in Oncology (B-ARGO) from the Institut Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2024 Jun; Vol. 168 (2), pp. 299-306. Date of Electronic Publication: 2024 Apr 17.

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Autor: Gately L; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. gately.l@wehi.edu.au.; Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia. gately.l@wehi.edu.au., Mesía C; Medical Oncology Service, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Sepúlveda JM; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain., Del Barco S; Medical Oncology Service, Institut Català d'Oncologia Girona, Girona, Spain., Pineda E; Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain., Gironés R; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain., Fuster J; Medical Oncology Service, Hospital Son Espases, Palma de Mallorca, Spain., Hong W; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia., Dumas M; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia., Gill S; Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia., Navarro LM; Medical Oncology Service, Hospital de Salamanca, Salamanca, Spain., Herrero A; Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain., Dowling A; Department of Medical Oncology, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia., de Las Peñas R; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain., Vaz MA; Medical Oncology Service, Hospital Ramón y Cajal, Madrid, Spain., Alonso M; Medical Oncology Service, Hospital Virgen del Rocio, Seville, Spain., Lwin Z; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Harrup R; Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia., Peralta S; Medical Oncology Service, Hospital Sant Joan de Reus, Reus, Spain., Long A; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Perez-Segura P; Medical Oncology Service, Hospital Clinico San Carlos, Madrid, Spain., Ahern E; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia., Garate CO; Medical Oncology Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Wong M; Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia., Campbell R; Department of Medical Oncology, Bendigo Health, Bendigo, VIC, Australia., Cuff K; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Jennens R; Department of Medical Oncology, Epworth Health, Richmond, VIC, Australia., Gallego O; Medical Oncology Service, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Underhill C; Department of Medical Oncology, Border Medical Oncology, East Albury, NSW, Australia., Martinez-Garcia M; Medical Oncology Service, Hospital del Mar, Barcelona, Spain., Covela M; Medical Oncology Service, Hospital Lucus Augusti, Lugo, Spain., Cooper A; Department of Medical Oncology, Liverpool Hospital, Liverpool, NSW, Australia., Brown S; Department of Medical Oncology, Ballarat Health Services, Ballarat, VIC, Australia., Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Torres J; Department of Medical Oncology, Goulburn Valley Health, Shepparton, VIC, Australia., Collins IM; Department of Medical Oncology, South West Regional Cancer Centre, Geelong, VIC, Australia., Gibbs P; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia., Balana C; Medical Oncology Service, Institut Català d'Oncologia, Badalona, Spain.; Badalona Applied Research Group in Oncology (B-ARGO), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2024 Feb; Vol. 166 (3), pp. 407-415. Date of Electronic Publication: 2023 Dec 28.